Amplification inhibitors can lead to false-negative results for PCR. In order to evaluate the reliability of PCR for the detection of Chlamydia pneumoniae, the presence of PCR inhibitors in 75 bronchoalveolar lavage specimens was assessed after treatment by various sample preparation methods. Specimens were collected from patients with acute respiratory infections, including four cases of proven C. pneumoniae infection. Substances inhibitory to the amplification of chlamydial DNA continued to be present in 12% of the samples treated according to the commonly used single-step proteinase K digestion and in 31% of the samples processed by heat treatment. However, the complexing of DNA-contaminating proteins and polysaccharides from digested specimens to cetyltrimethylammonium bromide (CTAB) followed by DNA extraction efficiently removed inhibitors from all experimental samples and provided subsequent identification of all positive clinical samples by PCR. The CTAB method and proteinase K treatment had comparable detection limits of approximately 0.01 inclusion-forming units. CTAB-based DNA purification of respiratory specimens is recommended to increase the diagnostic sensitivity of PCR and confidence in negative results.
Chlamydia pneumoniae is a frequent cause of communityacquired pneumonia (7) and is possibly associated with coronary atheroma (13, 17) . The recently described pathogen is far more difficult to recover from clinical specimens and to permanently grow in cell cultures than the other chlamydial species (7, 11, 12) . There is seroepidemiologic evidence that, independent of geographic regions, nearly everybody will be infected either once or repeatedly by C. pneumoniae (7) , though the majority of infections apparently will remain subclinical. The serodiagnosis of acute infection is sometimes possible by the microimmunofluorescence test but also problematic because of the late onset of antibody production, the common absence of detectable amounts of immunoglobulin M in reinfection (4, 7, 15) , and the lack of defined species-specific antigens. For a pathogen otherwise difficult to diagnose, the use of molecular biological detection methods such as PCR is efficient and reasonable, provided the results are thoroughly controlled. Avoiding false-positive results for PCR is a muchdiscussed topic while the prevention of false negatives is commonly less considered, though the inhibition of the DNA amplification process by substances present in clinical samples may seriously impede PCR-based diagnosis. For a commonly encountered pathogen such as C. pneumoniae, the presence of PCR inhibitors in a substantial number of specimens results in an unacceptably high proportion of false negatives. Therefore, three common sample preparation protocols were applied to clinical and experimental specimens in order to define the one most reliable for subsequent detection of C. pneumoniae by enzymatic DNA amplification. The clinical application of PCR on throat swabs has been previously reported (2, 3) , but the optimal sample sites for diagnosing C. pneumoniae infection by molecular biological yet been defined. In our experience, bronchoalveolar lavage (BAL) fluid, which contains cellular and soluble materials from the surfaces of the respiratory tract, is another valuable specimen and was used in this investigation.
Culture of C. pneumoniae. HEp-2 cells served as the host cell line for C. pneumoniae MUL-1, a regional respiratory isolate from our laboratory. The cell growth medium was Eagle's minimal essential medium with nonessential amino acids and 2 mM glutamine (EMEM) (GIBCO/BRL GmbH, Eggenstein, Germany), supplemented with 10% fetal calf serum (Biochrom KG, Berlin, Germany). Chlamydiae were continuously cultured as previously described (12, 14, 16, 19) (7) . The remaining samples were culture negative, and the patients were serologically unsuspicious for recent chlamydial infection. BAL samples were examined for C. pneumoniae DNA and used to determine the possible presence of amplification inhibitors after treatment by three sample preparation methods. While a 4-ml portion of each BAL sample was experimentally made positive by the addition of 60 IFU of strain MUL-1, another 4-ml portion was examined without alteration. All samples were centrifuged at 20,000
x g and 4°C for 30 min. The pellets were suspended in 60 RI of water; therefore, the samples with experimentally added chlamydiae contained 1 IFU/,u. Then, 10-pl portions of the experimentally positive samples as well as the samples without added chlamydiae were subjected to the different DNA preparation methods described below before PCR was performed.
Sample preparation methods. Samples in 10-pI portions were obtained as described above and subjected to three common methods of preparing material for DNA amplification.
(i) Heat treatment. Samples were boiled in 50 pl of water for 10 min and then used for PCR.
(ii) Single-step proteinase K treatment. According to the method of Campbell et al. (2) Figure 1 shows the C. pneumoniae detection limits of PCR and nonradioactive hybridization in relation to the sample preparation method as determined with 10-fold IFU dilutions. By using the single-step proteinase K treatment protocol (2) (3) . In another study with different oligonucleotide primers, 0.4 IFU of C. pneumoniae was the detection limit when proteinase K treatment followed by phenol-chloroform DNA extraction was used for sample preparation (6) . As less than 1 IFU could be distinctly detected, the number of chlamydiae present in suspension apparently exceeded the number retrievable by cell culture as represented by the IFU count. DNA amplification does not differentiate nonviable or nonreplicating organisms from cultivable organisms. Additionally, the biological meaning of the target sequence, which was obtained after PstI restriction analysis of cloned C. pneumoniae DNA (3), is uncertain, and the sequence may be repetitive within the chlamydial genome, thus contributing to the high sensitivity of PCR.
This investigation shows that depending on the sample preparation protocol applied, a substantial number of BAL specimens contain potent inhibitors of enzymatic DNA amplification, with the consequence of false-negative reactions. In a report on PCR detection of Chlamydia trachomatis on endocervical swabs, boiling was used for sample preparation and was found to be sufficient for the detection of 500 elementary bodies in experimental samples, but the detection limit was not further tested and clinical samples were not examined for the presence of inhibitors (10) . In this examination, boiling, obviously the most convenient sample preparation, was the least efficient method and was unacceptable for use with clinical BAL specimens subjected to C. pneumoniae PCR. The lysis buffer used here for the single-step proteinase K pretreatment was reported to contain an optimized combination of detergents (2) and is commonly used for PCR detection of C. pneumoniae. However, only the application of the more complex CTAB-based DNA purification protocol efficiently succeeded in removing PCR inhibitors from all BAL samples tested and permitted subsequent identification of all positive patients. The obvious disadvantage of the CTAB method is that additional steps are necessary to separate DNA and CTAB by the extraction and precipitation of DNA. A loss of target DNA in the course of extraction might be of concern, but use of the CTAB protocol on IFU dilutions without inhibitory activity yielded a sensitivity for the detection of C. pneumoniae at least equal to that of the single-step proteinase K sample treatment. Commercial kits to facilitate DNA purification without the loss of efficiency are urgently required, and their development also depends on better definitions of the PCR inhibitors present in clinical samples.
With the exception of the heme molecule and its derivatives (9), the inhibitors of enzymatic DNA amplification present in clinical samples are not well defined, and systematic studies of the inhibition of PCR are lacking. Acidic polysaccharides, which are present in the glycoproteins of respiratory secretions, are known to impede polymerases (8) . A sample preparation protocol consisting solely of the proteinase K treatment leads to the degradation of proteins and polypeptides but does not eliminate those inhibitory polysaccharide components from specimens. On the other hand, additional application of CTAB to heterogeneous mixtures of macromolecules results in the precipitation of proteins as well as polysaccharides and DNA can be recovered from the aqueous supernatant (18) . A possible copurification of PCR inhibitors with DNA has been described previously (5) but did not occur with the samples tested here. The effective removal of inhibitory polysaccharides from all specimens derived from the respiratory tract should be considered.
Several proposals for eliminating or monitoring the inhibition of DNA amplification have been made. With regard to the amplification of C. pneumoniae DNA from throat swabs, the control of possible inhibitors by testing various sample dilutions in parallel has been suggested (2) but this approach, apart from adding to the workload, simultaneously reduces the amount of PCR targets such that decreased diagnostic sensitivity may result. For BAL fluid, a highly diluted material, the largest possible sample volume appears to be appropriate. The routine addition of elementary bodies to a part of each clinical specimen as a control and screening method for PCR inhibitors carries a certain risk of sample contamination and again reduces the amount of each specimen available for diagnosis. The addition of an internal control to each PCR tube provides direct monitoring of inhibitory activity. For example, in a study testing BAL fluid for mycobacterial DNA, an internal control which contained the primer template sequences was constructed. Amplification of this internal control resulted in a PCR product larger than that obtained from the natural target sequence (1) . Though this approach checks for PCR inhibitors in the actual reaction mixture. thus avoiding parallel tests from a single specimen, it does not circumvent the need to further purify DNA in case inhibitors are present, at least if samples are not to be entirely excluded from further processing. If a substantial number of specimens can be expected to contain PCR inhibitors, as observed for 12% of the solely proteinase K-treated BAL samples in this examination, it may be more convenient to start sample processing by routinely purifying DNA from all specimens to be subjected to PCR by use of an apparently more efficient method like the CTAB protocol, even though it is more complex.
Culture methods for C. pneumoniae have been improved recently (14, 16, 19) , but since isolation is still time-consuming and labor-intensive and usually available only in specialized laboratories, further progress toward culture conditions more satisfactory to serve as the "gold standard" is mandatory.
Though not ideal for routine application either, PCR is a diagnostic alternative. Unfortunately, the sample preparation most effective in identifying positive patients was the least convenient, thus adding to the difficulties PCR already poses to the diagnostic routine. In summary, the risk of false negatives with suboptimal sample preparation protocols is unacceptably high for a frequently encountered pathogen. While this study focused only on optimizing PCR detection of C. pneumoniae by ensuring the accuracy of negative results, future studies will have to provide a correlation among PCR results, culture, and the clinical picture for a final evaluation of detection methods and further verification of the etiological role of C. pneumoniae in human disease.
